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Abstract 
Sterols are essential components of cellular membranes and shape their biophysical 
properties. The recently discovered family of Lipid transfer proteins Anchored at 
Membrane contact sites (LAMs) have been suggested to carry out intracellular sterol 
traffic using StART-like domains. Here, we studied the second StART-like domain of 
Lam4p from S. cerevisiae by NMR. We predicted the structural model of Lam4S2 
and we validate it using secondary structure propensities obtained from the NMR 
analysis of the protein backbone. NMR data revealed enhanced µs-ms flexibility for 
several functionally important regions, identified the sterol binding site, and 
suggested the role of membrane interactions on thermodynamics of sterol binding. 
Highlights 
¥ An NMR assignment of Lam4S2 identified significant conformational exchange. 
¥ Lam4S2 binding to sterol causes structural changes to the StART-like cavity. 
¥ In a non-membrane environment, the upper limit of sterol exchange is in the 1-10 
s-1 range. 
 
Keywords  
Lipid transfer proteins, Membrane contact sites, Intracellular sterol traffic, Protein-
lipid interaction, Nuclear magnetic resonance 
 
Abbreviations 
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LAM, Lipid transfer protein Anchored at a Membrane contact site;  
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LTP, Lipid Transfer Protein; 
NMR, Nuclear Magnetic Resonance.  
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Introduction 
Sterols are essential components of cellular membranes where their concentration 
determines vital biophysical properties, such as fluidity, rigidity and thickness [1, 2]. 
Like the majority of lipid molecules, sterols are predominantly made in the 
endoplasmic reticulum (ER) where they are present at low concentration (5 mol% of 
lipids). Along the secretory pathway, cholesterol in mammalian cells and ergosterol 
in fungal cells become enriched in the trans-Golgi and plasma membrane, where 
they account for 30-40 mol% of total lipids [3-5]. The transport of newly synthesised 
sterols to the plasma membrane is bidirectional and rapid (t1/2 <5 min). Furthermore, 
it is largely independent from vesicular traffic and it is likely to be mediated by 
soluble sterol Lipid Transfer Proteins (LTPs) [6-9]. Nevertheless, a comprehensive 
description of the mechanisms of ER to plasma membrane sterol transport is still 
missing.  
We have recently discovered a family of transmembrane proteins that we called Lipid 
transfer proteins Anchored at Membrane contact sites (LAMs) [10]. Yeast has six 
LAMs all localised to membrane contact sites between the ER and other organelles. 
They contain domains that are distant homologues of Steroidogenic Acute lipid 
Transfer (StART) domains, as identified by HHsearch [11], and these domains have 
been shown to solubilise [10] and transfer [12] sterols. S. cerevisiae contains three 
paralogous pairs of LAMs, which localise to two places: Lam1/3p and Lam2/4p 
localise to ER- plasma membrane junctions, while Lam5/6p localise to multiple 
internal contact sites between the ER and both mitochondria and vacuole [10, 12, 
13]. We proposed that Lam1Ð4p are involved in intracellular sterol traffic between ER 
and plasma membrane thanks to their predicted StART-like domains [10]. The in 
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vitro ability to transfer sterol was matched by involvement in intracellular sterol traffic 
in vivo [10, 12]. In addition, action of LAM domains in creating resistance in yeast to 
the antifungal drug Amphotericin B domains suggested that the domains of  
Lam2/4/5/6p and the human LAMs all bind sterol [10]. 
The ability to solubilise lipids into aqueous solution is a general property of StART-
like domains. They have a characteristic β-grip fold that forms a deep hydrophobic 
pocket capable of harbouring a lipid. The minimal StART-like domain consists of 
~170 aa forming a seven stranded curved β-sheet that curves round (ÒgripsÓ) one 
long helix and 2 short helices. Many StART-like families can be grouped together by 
structural and remote sequence homology into a large StAR-kin superfamily. Like 
other superfamilies, these relationships are discoverable not through primary 
structure alone, but require three-dimensional alignment [14]. The β-grip has an 
internal cavity between the helices and the sheet with a typical volume 400-7003, 
which allows one lipid to bind inside [15]. There is as yet no structural evidence to 
support the structural predictions made for the StART-like domains in LAMs. Here, 
we used solution NMR to probe the structural and dynamic features of the second 
StART-like domain of Lam4p (Lam4S2) in its apo- and holo- states.  
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Materials and methods 
Protein expression and purification 
Lam4S2 (235 residues, sequence MGGSHHHHHHGMASHHHHHARAM + Lam4 
residues 946-1155 + DV-stop) was produced as previously described [10], with some 
modifications for isotope labelling [16]. A single colony of BL21(DE3) cells 
transformed with pTrcHis11-Lam4S2 was grown overnight at 30¡C in LB medium. 
The culture was diluted into unlabelled M9 medium (45 mM Na2HPO4, 20 mM 
KH2PO4, 10 mM NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 20 mM NH4Cl) + 2.5% LB at 
37¡C. At OD600 ~0.5 the culture was diluted 1:120,000 in 100 ml of unlabelled M9 
medium + 2.5% LB and left overnight at 30¡C. Log-phase growing cells were 
resuspended in 500 ml of labelled M9 medium made with 45 mM Na2HPO4, 20 mM 
KH2PO4, 10 mM NaCl, 1 mM MgSO4, 0.1 mM CaCl2, 20mM 15NH4Cl (Goss Scientific, 
Cat. No. NLM467) + 2.5% LB and transferred at 37¡C. At OD600 = 0.5 the culture is 
diluted in 2 litres of labelled M9 medium + 2.5% LB. Protein overexpression was 
induced at OD600 = 0.5 with 0.2 mM IPTG for 6 hours at 37¡C. Cells were lysed in 
lysis buffer: 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 0.5 mM DTT, 1 
cOmplete EDTA-free protease inhibitor cocktail tablet (Roche, Cat.no. 
11873580001), 0.1 mg/ml lysozyme chloride form. The protein was purified following 
the previously published protocol [10], but desalted into a buffer optimised for NMR: 
10 mM PIPES pH 6.8, 50 mM L-Arginine (Sigma, Cat.no. A5006), 50 mM L-
Glutamate (Sigma, Cat.no. G1626), 49 mM NaCl, 1 mM KCl [17].  
Double labelled Lam4S2 samples (13C, 15N) were grown according to the above 
protocol in presence of both 20 mM 15NH4Cl and 10 mM D-[13C]-glucose (Goss 
Scientific, Cat. No. CLM1396). Triple labelled Lam4S2 samples (2H, 13C, 15N) were 
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grown in 2H2O according to the above protocol in presence of both 20 mM 15NH4Cl 
and 10 mM D-[13C]-glucose (Goss Scientific, Cat. No. CLM1396). This followed a 
2H2O-adaptation of BL21(DE3) E. coli colonies which were selected from a 2H2O-
based M9 minimal medium agar plate grown for 2 days at 37 ¡C.  
 
Backbone chemical shift assignment 
Assignment experiments for Lam4S2 were carried out at protein concentrations from 
0.35 to 0.5 mM in the following NMR buffer: 10 mM PIPES pH 6.8, 50 mM L-Arg + L-
Glu pH 6.8, 49 mM NaCl, 1 mM KCl, 10 % 2H2O. On the 1H-13C-15N sample HNCA, 
HNCACB, HN(CA)CO, HNCO and HN(CO)CA [18] BEST-TROSY experiments were 
recorded at 288 K, 293 K, 298 K and 303 K (15¡C to 30¡C) using Bruker Avance II 
600 MHz, equipped with the TCI cryogenically cooled probe (MRC Biomedical NMR 
Centre, Mill Hill, London), a Varian INOVA 600 MHz magnet (Faculty of Biological 
Sciences, University of Leeds), and Bruker Avance II 900 MHz, equipped with the 
TCI cryogenically cooled probe (Biomolecular NMR facility, University of 
Birmingham). Assignment experiments on the triple labelled 2H-, 13C-, 15N-Lam4S2 
sample were carried out at 283 K on a Bruker DRX800 spectrometer equipped with a 
cryo-probe (Cross Faculty NMR Centre, Imperial College London). These 
experiments were recorded in their TROSY implementations for use with backbone 
chemical shift assignments: HNCO, HN(CO)CA, HNCACB, HN(CA)CO, 
HN(CO)CACB and HNCA. Data were processed using NMRpipe [19]. 
Backbone assignment of Lam4S2 was initially performed semi-automatically using 
MARS [20], then subsequently confirmed and completed manually. 
 
 9 
Chemical shift analysis and homology modelling 
To gain structural information from the backbone chemical shift assignment of 
LAM4S2 the assigned chemical shifts were used with TALOS-N [21] which predicted 
secondary structure elements from the observed experimental shifts. The secondary 
structure calculation from TALOS-N was used as the secondary structure input for i-
Tasser [22-24] to obtain a Lam4S2 model.  
 
Cholesterol titrations and line shape analysis 
Two 140 μM 2H-, 13C-, 15N-Lam4S2 samples were titrated with either the sterol 
ligand or a control. The ligand is a preparation of 6 mM cholesterol : 30 mM methyl 
β-cyclodextrin (MβCD) [25], while the control sample contains only 30 mM MβCD. 
The protein samples, and both additives are dissolved in the same NMR buffer: 10 
mM PIPES pH 6.8, 50 mM L-Arg + L-Glu pH 6.8, 49 mM NaCl, 1 mM KCl, 10 % 
2H2O, Both samples were titrated at protein:cholesterol ratios of 1:0, 1:0.25, 1:0.5, 
1:0.75, 1:1, 1:2 and 1:4. 1H-, 15N-TROSY-HSQC spectra were recorded at each data 
point at 283K on a Bruker DRX800 spectrometer equipped with a cryo-probe 
Titration data were processed with exponential line broadening using nmrPipe [19] 
then imported into TITAN [26] for line shape analysis. Data were fitted to a two-state 
ligand binding model in a two-stage process: chemical shifts and linewidths of the 
free state were determined using the first spectrum only, then chemical shifts of the 
bound state, linewidths of all states, and the binding model parameters Kd and koff 
were fitted using the entire dataset. 
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Results and discussion  
Lam4S2 NMR fingerprint 
The 1H, 15N HSQC-TROSY of Lam4S2 (Figure 1) shows the NMR fingerprint of the 
protein recorded after optimising the buffer conditions for NMR from those optimal for 
in vitro binding assays [10] to a lower salt buffer that contains 50 mM L-Arginine/L-
Glutamate solution to improve signal-to-noise ratio and increase protein solubility 
[17]. The 1H, 15N HSQC-TROSY of Lam4S2 (Figure 1) contains 204 backbone amide 
peaks. This corresponds to 92% of the 222 peaks, which are expected to be 
observable from the 235 residue LAM2S2 construct. The chemical shift dispersion 
indicates a folded protein, and the absence of multiple peaks for a single backbone 
amide suggested a single conformation. The intense peaks detected at proton 
chemical shifts of ~8 ppm are probably part of the unfolded 11-histidine tag. 
Additionally to the backbone amides, two tryptophan amine resonances are 
observed at proton chemical shifts of 10.5 and 11.2 ppm.  
 
Lam4S2 backbone assignment 
The backbone assignment of Lam4S2 is based on double- and triple-labelled 
samples of Lam4S2. Analysis of the initial data recorded on the double-labelled 
sample (15N-13C-Lam4S2) could assign only 50% of the residues because the low 
quality of the triple resonance spectra (particularly, HNCACB and HN(CA)CO 
experiments) was not enough to obtain the unambiguous backbone assignments. 
The lack of signal in triple resonance spectra of the protonated sample is due, in 
part, to the relatively large size of the polypeptide (MW = 26.5 kDa). This led us to 
adopt an assignment strategy employing deuteration to improve the relaxation 
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properties of the sample and improve the sensitivity of the assignment experiments. 
Furthermore, spectral resolution and sensitivity were improved by working at a 
higher magnetic field (18.8 T instead of 14.1 T) and recording the experiments using 
TROSY-based triple resonance experiments. 
Fractional deuteration (~75%) of Lam4S2 increased the number of peaks observed 
in the triple resonance experiments Significant line broadening was observed for a 
number of peaks in 2D and 3D spectra, apparently suggesting that some parts of the 
protein involved into a µs-ms exchange process, that significantly complicate the 
assignments. Finally, a combination of triple resonance experiments recorded for 
non-deuterated and deuterated proteins at several magnetic fields and temperatures 
allowed backbone assignments for ~54% protein construct (Fig. 2A, B). This partial 
assignment (Figure 1) covers 70% of the pseudo-residues observed but only 54% of 
the protein construct. Figures 2A and 2B illustrate the parts of Lam4S2 we assigned, 
and they identify the regions for which we did not obtain an assignment. It is 
apparent that the unstructured loops of the protein where readily assigned while the 
core residues of the β-sheets (β1, β3, β4, β5, β6, and β7) forming the hydrophobic 
cavity are largely unassigned due to missing chemical shift data in either the 3D 
experiments or the 2D and 3D experiments.  
These observations are likely due to conformational exchange on a millisecond to 
microsecond timescale. Notably, β6 a central strand within the β-sheet) contains a 
contiguous hydrophobic stretch of amino acids ÔIFLFWÕ (1082-1086) that is 
unassigned (blue patch in Fig. 2B). In the predicted structure, the two phenylalanines 
are solvent exposed and flanked by additional hydrophobic residues exposed on 
neighbouring strands. We suggest that this may be an interaction site for a separate 
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domain. In the absence of its binding partner, this segment could contribute to self-
association, which would introduce the exchange broadening observed in the NMR 
spectrum. Interestingly, both Lam2p and Lam4p possess two conserved StART-like 
domains in their sequence, which may interact with each other via this surface and 
function in a co-regulatory role. 
The resulting partial chemical shift assignment of Lam4S2 is not sufficient for de 
novo structural calculations. Therefore, we employed homology modelling restrained 
by the chemical shift based secondary structure prediction of TALOS-N to obtain a 
structural model of Lam4S2 (Figure 2). 
 
Residues affected by sterol binding 
The available backbone assignment of Lam4S2 was used to determine the role of 
the assigned residues in sterol binding. Titration of a MβCD:sterol complex into a 
Lam4S2 protein sample resulted in the decrease of peak intensities of a small set of 
apo peaks, while additional cholesterol-bound peaks appeared at different distinct 
sets of chemical shifts. NMR data are shown in Figure 3A for selected peaks. The 
cholesterol-bound peaks increased in intensity with increasing cholesterol 
concentrations. These results suggest that the cholesterol:Lam4S2 complex is in 
slow exchange on the NMR chemical shift timescale. The control set of titrations of 
MβCD with LAM4S2 showed no changes in chemical shifts (data not shown) 
confirming that the observed chemical shift changes are indeed due to cholesterol 
binding. 
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Cholesterol titration experiments allowed us to identify the residues involved in sterol 
binding as being in the N-terminal loop (S954, A956, D965), β1 (I971 and E973), α2 
(T993 and E994), β2 (E1010), and others in the loops between the antiparallel β-
sheets (S1018, T1067, G1073, and H1089). Additional to those residues identified 
via their backbone amide chemical shifts it was striking that one of the tryptophan 
side chain amines showed chemical shift changes upon cholesterol binding, while 
the other tryptophan did not display any changes in chemical shift. Considering the 
structural information on Lam4S2, W1086 was predicted to face outside the binding 
pocket, while W1102 was predicted to face inside the binding pocket [10]. So this is 
very likely to be the residue showing the significant chemical shift.  
A more quantitative titration of the Lam4S2 cholesterol was conducted to obtain 
kinetic parameters of the cholesterol binding. Analysis was conducted by quantum 
mechanical simulation of the titration data and subsequent fitting of the 2D 
experiment to allow a quantitative analysis of the resonance lineshape [26]. The 
experimental data and the simulated data for selected peaks are shown in Figure 3A. 
When selecting a peak for lineshape analysis a region of interest and the peak 
position are chosen in all spectra, and this input is used to fit the lineshape of all 
selected peaks. Examples of peak fitting are provided in Supplementary Figures 1 
and 2. Data are then fitted to a two-state ligand-binding model in a two-stage 
process. First, the chemical shifts and the linewidth of the free (protein only) state 
were determined. Second, those parameters were used with the chemical shift of the 
cholesterol bound state and the linewidths of all states to fit the parameters Kd and 
koff to the entire dataset (Figure 3B). The Kd obtained was 140 µM. This is 2 orders of 
magnitude higher than the dissociation constant measured when the same domain 
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was presented with sterol in liposome bilayers (Kd = 0.5 μM) [10]. This large 
difference might be explained by structural analysis of other StART domains. 
StARD4 undergoes conformational changes in the C-terminal helix and the Ω-loop 
when it interacts with a bilayer [27]. These changes expose the internal cavity and 
allow lipid entry/exit. If LAMs have a similar opening mechanism, cyclodextrins would 
be very poor donors since they do not mimic a membrane, so the entry site of the 
domain would not be held open.  From the Kd it was possible to estimate a koff of 
about 6 molecules per second. This value falls in an acceptable range if compared 
with the rate of transfer of other StART domains [27], and once the sterol molecule is 
bound in the hydrophobic pocket, the role of membrane interaction could be less 
relevant for lipid unloading. However, the clear message is that specific residues in 
Lam4S2 are affected by the addition of cholesterol and hence involved in sterol 
binding: part of the long helix (α3), residues along α2 and the Ω-loop contacting α3, 
and the assigned tryptophan (W1102). 
  
In summary we can say that the chemical shift information obtained during the 
assignment of Lam4S2 has allowed us to present a refined homology model. This 
model is consistent with sterol binding inside an internal hydrophobic cavity, and 
therefore with the domain assuming the StART-like fold predicted for it by 
bioinformatics approaches [10, 28]. Furthermore, structural changes upon specific 
sterol binding could be observed. Any further studies that would allow a more in 
depth characterisation of the sterol binding need to address the conformational 
exchange due to domain association Ñ ideally by working in the natural context of 
the twin StART-like domains. 
 15 
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Figure/Table Legends  
Figure 1.  
Lam4S2 assignment. Partially assigned 1H, 15NÐHSQC-TROSY spectrum of the 
recombinant 2H, 13C, 15N-Lam4S2 domain. The peaks are labelled using the single 
letter amino acid code followed by their position in the recombinant Lam4S2 
construct. 
 
Figure 2.  
Secondary structure determination using TALOS-N and comparison to 
Lam4S2 homology model. (A) Distribution of assigned peaks over the Lam4S2 
sequence. Blue bars represent where an assignment is available; elsewhere 
experimental data are missing. (B) Homology model of Lam4S2. Highlighted in green 
are the residues for which experimental data in the form of a chemical shift 
assignment are available; highlighted in blue is the unassigned hydrophobic patch 
potentially involved in domain-domain interaction. (C) The predicted secondary 
structure of Lam4S2 using TALOS N and the available chemical shift data. The 
Lam4S2 sequence is predicted to consist of 3 α-helices and 7 β-strands. Helices are 
located between residues 59-65, 67-80, 182-217 with a kink at residues 191/192, 
similar to that seen in both PCTP and StARD5 (1LN1 and 2R55 respectively), β-
strands are located between residues 48-51, 88-90, 102-109, 122-124, 136-141, 
155-164 and 171-179. (D) Lam4S2 StART-like domain with detailed secondary 
structure elements as obtained by prediction and verified by NMR chemical shifts. 
Residues involved in sterol binding (annotated balls), including W1102 (sticks), and 
the residues in the Ω-loop contacting α3 are mapped on the model. 
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Figure 3. 
Analysis of the Lam4S2 interaction with cholesterol. (A) Observed and fitted 1H, 
15N-HSQC-TROSY spectra of 140 μM 2H-13C-15N-Lam4S2 upon titration of 
MβCD:cholesterol for selected peaks included in the global fit of binding model 
parameters. (B) Binding model parameters for the interaction of Lam4S2 with 
cholesterol. 
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Figures/Tables  
Figure 1. 
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Figure 2. 
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Figure 3.  
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Supplementary Material  
Supplementary Figure 1. 
 
Line shape analysis using TITAN. Grid view off all fits used to calculate the 
cholesterol binding kinetics to Lam4S2. From left to right: the Lam4S2-to-cholesterol 
ratio increases from 1:0 to 1:4. Fits are shown as contour plot. 
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Supplementary Figure 2. 
 
3D line shape fits obtained by TITAN. The experimental data (grey) Ñ here for a 
TRP side chain residue Ñ are overlaid with the simulated data (red), which were 
obtained using TITAN during the calculation of the cholesterol binding kinetics. 
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